Expertise in
3
conditions

Dr. Elizabeth R. Kessler

Hospital Medicine
Office
1665 Aurora Ct Fl 1, 
Aurora, CO 
Accepting New Patients
Offers Telehealth
Expertise in
3
conditions
Office
1665 Aurora Ct Fl 1, 
Aurora, CO 

Overview

Elizabeth Kessler is a Hospital Medicine provider practicing medicine in Aurora, Colorado.

Dr. Kessler is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Orchiectomy, and Penectomy.

She is actively involved in clinical research, co-authoring 75 peer reviewed articles and participating in 11 clinical trials. Dr. Kessler is currently accepting new patients.

Specialties

Hospital Medicine

Licenses

Internal Medicine in CO

Hospital Affiliations

Uchealth Highlands Ranch Hospital
University Of Colorado Hospital Authority
Uchealth Broomfield Hospital
Medical Center Of The Rockies
Longs Peak Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Denver Health Medical Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Longevity Health Plan
  • MEDICARE SNP
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Rocky Mountain Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Office
1665 Aurora Ct Fl 1, Aurora, CO 80045

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
A Phase 2 Study of M6620 (VX-970, Berzosertib) in Combination With Carboplatin Compared With Docetaxel in Combination With Carboplatin in Metastatic Castration-Resistant Prostate Cancer
A Phase 2 Study of M6620 (VX-970, Berzosertib) in Combination With Carboplatin Compared With Docetaxel in Combination With Carboplatin in Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Drug, Other
Study Drugs: Berzosertib, Carboplatin, Docetaxel
Study Phase: Phase 2
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Drug
Study Phase: Phase 3
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Completed
Publish Date: June 25, 2026
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2026
Intervention Type: Procedure, Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 2
Square Wave Testosterone Therapy in Castration Resistant Prostate Cancer
Square Wave Testosterone Therapy in Castration Resistant Prostate Cancer
Enrollment Status: Completed
Publish Date: November 06, 2025
Intervention Type: Drug
Study Drug: Transdermal Testosterone
Study Phase: Early Phase 1
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
An Open Label, Randomized, Phase II Trial of Metabolic Complications in Patients Treated With Enzalutamide vs Standard ADT for the Treatment of Hormone Sensitive Prostate Cancer
An Open Label, Randomized, Phase II Trial of Metabolic Complications in Patients Treated With Enzalutamide vs Standard ADT for the Treatment of Hormone Sensitive Prostate Cancer
Enrollment Status: Completed
Publish Date: May 11, 2025
Intervention Type: Drug
Study Drugs: Enzalutamide, Leuprolide acetate, Goserelin acetate, Histrelin acetate, Triptorelin, Degarelix
Study Phase: Phase 2
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4): a Multicentre, Randomised, Controlled, Phase III Study
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4): a Multicentre, Randomised, Controlled, Phase III Study
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
View 9 Less Clinical Trials

75 Total Publications

A Phase 2 Study of Berzosertib in Combination with Carboplatin compared to Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.
A Phase 2 Study of Berzosertib in Combination with Carboplatin compared to Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.
Journal: Cancer research communications
Published: July 20, 2026
Similar Doctors
Expertise in
1
conditions
Dr. Susan L. Calcaterra
Hospital Medicine | Addiction Medicine
Expertise in
1
conditions
Dr. Susan L. Calcaterra
Hospital Medicine | Addiction Medicine
Referral may be required

University Physicians Incorporated

12605 E 16th Ave, Uchealth Anschutz Medical Campus, 
Aurora, CO 
 (0.4 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Susan Calcaterra is a Hospital Medicine specialist and an Addiction Medicine provider practicing medicine in Aurora, Colorado. Dr. Calcaterra is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Opioid Use Disorder. Dr. Calcaterra is currently accepting new patients.

Expertise in
5
conditions
Dr. Stanton R. Elzi
Hospital Medicine
Expertise in
5
conditions
Dr. Stanton R. Elzi
Hospital Medicine
Referral may be required

Wheat Ridge Internal Medicine

7821 West 38th Avenue, 
Wheat Ridge, CO 
 (13.2 miles away)
303-422-2343
Languages Spoken:
English
See accepted insurances

Stanton Elzi is a Hospital Medicine provider practicing medicine in Wheat Ridge, Colorado. Dr. Elzi is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Seasonal Affective Disorder (SAD), Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Paroxysmal Supraventricular Tachycardia (PSVT), and Atrial Tachycardia. Dr. Elzi is board certified in American Board Of Internal Medicine.

Expertise in
2
conditions
Dr. Mauricio L. Waintrub
Hospital Medicine
Expertise in
2
conditions
Dr. Mauricio L. Waintrub
Hospital Medicine
Referral may be required
Before you request

Rocky Mountain Internal Medicine

1525 Raleigh Street, 
Denver, CO 
 (9.7 miles away)
303-433-2565
Experience:
44+ years
Languages Spoken:
English, Russian, Spanish
See accepted insurances
Accepting New Patients

Mauricio Waintrub is a Hospital Medicine provider practicing medicine in Denver, Colorado. He has been practicing medicine for over 44 years. Dr. Waintrub is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Vitamin D Deficiency, Seasonal Affective Disorder (SAD), Menopause, and Angiomyoma. Dr. Waintrub is board certified in American Board Of Internal Medicine. Dr. Waintrub is currently accepting new patients.

Frequently Asked Questions about Dr. Elizabeth R. Kessler

How do I make an appointment with Dr. Elizabeth R. Kessler?

You can book an appointment with Dr. Elizabeth R. Kessler by calling their office at 720-848-0170. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Elizabeth R. Kessler a top-rated expert for Upper Tract Urothelial Carcinoma (UTUC)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Elizabeth R. Kessler is classified as an Distinguished expert for Upper Tract Urothelial Carcinoma (UTUC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Elizabeth R. Kessler specialize in?

While Dr. Elizabeth R. Kessler is a Hospital Medicine, they have specific expertise in Upper Tract Urothelial Carcinoma (UTUC), Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hospital Medicine.

Does Dr. Elizabeth R. Kessler participate in research or clinical trials?

Yes. Dr. Elizabeth R. Kessler has published 75 articles and abstracts on conditions like Upper Tract Urothelial Carcinoma (UTUC). You can view a list of Dr. Elizabeth R. Kessler's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Elizabeth R. Kessler accept my insurance?

Dr. Elizabeth R. Kessler accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 720-848-0170 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kessler's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile